When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...

Many people with multiple sclerosis (MS) may wonder whether trying a certain diet — or eliminating a certain food group from their diet — can ward off MS symptoms, like fatigue or cognitive ...